Seelos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | BuyUS$99,999 | Raj Mehra | Individual | 591.85 | US$168.96 | |
30 Nov 23 | BuyUS$100,223 | Michael Golembiewski | Individual | 648.44 | US$154.56 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,135 | 0.49% |
Institutions | 45,037 | 10.3% |
General Public | 388,786 | 89.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 937.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
18,113 | US$6.4k | 223% | no data | |||
10,805 | US$3.8k | 711% | no data | |||
8,477 | US$3.0k | 282,000% | no data | |||
4,085 | US$1.4k | 492% | 0.02% | |||
2,194 | US$777.5 | 0% | no data | |||
1,446 | US$512.4 | 0% | no data | |||
679 | US$240.6 | 0% | no data | |||
675 | US$239.2 | -51.5% | no data | |||
435 | US$154.2 | 0% | no data | |||
95 | US$33.7 | -60.6% | no data | |||
62 | US$22.0 | 0% | no data | |||
32 | US$11.3 | 10.3% | no data | |||
31 | US$11.0 | 0% | no data | |||
12 | US$4.2 | -7.69% | no data | |||
9 | US$3.2 | 0% | no data | |||
7 | US$2.5 | 0% | no data | |||
7 | US$2.5 | 0% | no data | |||
2 | US$0.7 | 0% | no data | |||
1 | US$0.4 | 0% | no data | |||
1 | US$0.4 | 0% | no data | |||
1 | US$0.4 | 0% | no data | |||
1 | US$0.4 | 0% | no data | |||
1 | US$0.4 | 0% | no data | |||
1 | US$0.4 | 0% | no data |